• Citer

Mitoxantrone-containing regimen for treatment of childhood acute leukemia (AML) and analysis of prognostic factors: results of the EORTC Children Leukemia Cooperative Study 58872.

par Behar, C;Suciu, Stefan ;Benoît, Yves;Robert, Alain;Vilmer, E;Boutard, Patrick;Bertrand, Yves;Lutz, Pierre;Ferster, Alina ;Tokaji, E;Manel, Anne-Marie;Solbu, Gabriel;Otten, Jacques
Référence Medical and pediatric oncology, 26, 3, page (173-179)
Publication Publié, 1996-03

Article révisé par les pairs

• Détails
• Contenu

Titre:	Mitoxantrone-containing regimen for treatment of childhood acute leukemia (AML) and analysis of prognostic factors: results of the EORTC Children Leukemia Cooperative Study 58872.
Auteur:	Behar, C; Suciu, Stefan; Benoît, Yves; Robert, Alain; Vilmer, E; Boutard, Patrick; Bertrand, Yves; Lutz, Pierre; Ferster, Alina; Tokaji, E; Manel, Anne-Marie; Solbu, Gabriel; Otten, Jacques
Informations sur la publication:	Medical and pediatric oncology, 26, 3, page (173-179)
Statut de publication:	Publié, 1996-03
Sujet CREF:	Pédiatrie
	Cancérologie
	Hématologie
MeSH keywords:	Vincristine -- administration & dosage
Note générale:	Clinical Trial
	Journal Article
Langue:	Anglais
Identificateurs:	urn:issn:0098-1532
	info:doi/10.1002/(SICI)1096-911X(199603)26:3<173::AID-MPO5>3.0.CO;2-H
	info:pii/10.1002/(SICI)1096-911X(199603)26:3<173::AID-MPO5>3.0.CO;2-H
	info:pmid/8544799